Drug Information

Drug General Information
Drug ID
D0P9HX
Former ID
DNC002936
Drug Name
3-Beta-Hydroxy-5-Androsten-17-One
Drug Type
Small molecular drug
Indication Discovery agent Investigative [551393]
Structure
Download
2D MOL

3D MOL
Formula
C19H28O2
Canonical SMILES
CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C
InChI
1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14?,15?,16?,18-,19-/m0/s1
InChIKey
FMGSKLZLMKYGDP-INNQQZFDSA-N
CAS Number
CAS 53-43-0
PubChem Compound ID
9860744
PubChem Substance ID
14824759, 24153822, 45283029, 47359653, 47879859, 48328815, 49600751, 50123753, 50123754, 50172730, 103275268, 126522997, 127867641, 142460765, 233769779
Target and Pathway
Target(s) Estradiol 17 beta-dehydrogenase 1 Target Info Inhibitor [551393]
3-beta-HSD Target Info Inhibitor [551393]
BioCyc Pathway Superpathway of steroid hormone biosynthesis
Estradiol biosynthesis I
KEGG Pathway Steroid hormone biosynthesis
Metabolic pathways
Ovarian steroidogenesis
NetPath Pathway FSH Signaling Pathway
PANTHER Pathway Androgen/estrogene/progesterone biosynthesis
PathWhiz Pathway Androgen and Estrogen Metabolism
Reactome The canonical retinoid cycle in rods (twilight vision)
WikiPathways Steroid Biosynthesis
Metabolism of steroid hormones and vitamin D
Prostate Cancer
References
Ref 551393How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
Ref 551393How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.